Saul Centers Bilan de santé

Santé financière contrôle des critères 0/6

Saul Centers possède un total de capitaux propres de $508.7M et une dette totale de $1.5B, ce qui porte son ratio d'endettement à 293.5%. Son actif total et son passif total sont $2.1B et de $1.6B. L'EBIT de Saul Centers est $124.2M ce qui fait que son ratio de couverture des intérêts 2.5. Elle dispose de liquidités et de placements à court terme de $8.5M.

Informations clés

293.5%

Ratio d'endettement

US$1.49b

Dette

Ratio de couverture des intérêts	2.5x
Argent liquide	US$8.51m
Fonds propres	US$508.68m
Total du passif	US$1.60b
Total des actifs	US$2.11b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Saul Centers: A 6% Yielding Shopping Center REIT Great For Income-Oriented Investors

Aug 02

Saul Centers: An Overlooked Shopping Center REIT Income Investors Should Consider

Mar 13

Shareholders Will Probably Not Have Any Issues With Saul Centers, Inc.'s (NYSE:BFS) CEO Compensation

May 02

Saul Centers, Inc. (NYSE:BFS) Delivered A Better ROE Than Its Industry

Feb 17

Saul Centers' (NYSE:BFS) Shareholders Are Down 45% On Their Shares

Jan 13

Saul Centers: Revenue Outlook Remains Positive Despite Retail-Heavy Portfolio

Dec 18

Saul Centers declares $0.53 dividend

Dec 10

Have Insiders Been Buying Saul Centers, Inc. (NYSE:BFS) Shares?

Dec 09

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de BFS ( $68.3M ) ne couvrent pas ses passifs à court terme ( $87.0M ).

Passif à long terme: Les actifs à court terme de BFS ( $68.3M ) ne couvrent pas ses passifs à long terme ( $1.5B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de BFS ( 291.8% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de BFS est passé de 186.1% à 293.5% au cours des 5 dernières années.

Couverture de la dette: La dette de BFS n'est pas bien couverte par le flux de trésorerie opérationnel ( 8.4% ).

Couverture des intérêts: Les paiements d'intérêts de BFS sur sa dette ne sont pas bien couverts par l'EBIT ( 2.5 x couverture).

Saul Centers Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.59 per share

Second quarter dividend of US$0.59 announced

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Saul Centers: A 6% Yielding Shopping Center REIT Great For Income-Oriented Investors

Upcoming dividend of US$0.59 per share

First quarter dividend of US$0.59 announced

Saul Centers, Inc. Declares Quarterly Dividends on Common Stock, Payable on July 31, 2024

New minor risk - Shareholder dilution

Consensus EPS estimates increase by 14%

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

New major risk - Revenue and earnings growth

Upcoming dividend of US$0.59 per share

Saul Centers, Inc., Annual General Meeting, May 17, 2024

Fourth quarter dividend of US$0.59 announced

Saul Centers, Inc. Declares Quarterly Dividends, Payable on April 30, 2024

Saul Centers: An Overlooked Shopping Center REIT Income Investors Should Consider

New minor risk - Shareholder dilution

Independent Director recently sold US$236k worth of stock

New minor risk - Shareholder dilution

Full year 2023 earnings released: EPS: US$1.73 (vs US$1.63 in FY 2022)

Upcoming dividend of US$0.59 per share at 6.0% yield

Saul Centers Declares Quarterly Dividend Payable on January 31, 2024

Saul Centers, Inc. Announces Executive Changes, Effective December 31, 2023

Third quarter 2023 earnings released: EPS: US$0.42 (vs US$0.38 in 3Q 2022)

Saul Centers, Inc. Announces the Resignation of Christopher H. Netter as Executive Vice President – Leasing, Effective December 31, 2023

Upcoming dividend of US$0.59 per share at 6.8% yield

Chairman & CEO recently bought US$369k worth of stock

Saul Centers: Safe Yield, Attractive Upside

Price target increased by 7.9% to US$41.00

Chairman & CEO recently bought US$242k worth of stock

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: US$0.43 (vs US$0.43 in 2Q 2022)

Upcoming dividend of US$0.59 per share at 6.5% yield

President & COO recently bought US$116k worth of stock

First quarter 2023 earnings released: EPS: US$0.45 (vs US$0.44 in 1Q 2022)

Upcoming dividend of US$0.59 per share at 6.2% yield

Chairman & CEO recently bought US$364k worth of stock

Chairman & CEO recently bought US$104k worth of stock

Price target decreased by 14% to US$42.00

Full year 2022 earnings released: EPS: US$1.63 (vs US$1.57 in FY 2021)

Now 20% undervalued

Now 20% undervalued

Upcoming dividend of US$0.59 per share

Saul Centers, Inc. Declares Quarterly Dividend, Payable on January 31, 2023

Saul Centers declares $0.59 dividend

Price target decreased to US$49.00

Insufficient new directors

Third quarter 2022 earnings released: EPS: US$0.38 (vs US$0.44 in 3Q 2021)

Saul Centers reports Q3 results

Upcoming dividend of US$0.59 per share

Saul Centers, Inc. Declares Quarterly Dividend on Common Stock, Payable on October 31, 2022

Saul Centers declares $0.59 dividend

Second quarter 2022 earnings released: EPS: US$0.43 (vs US$0.42 in 2Q 2021)

Upcoming dividend of US$0.59 per share

Saul Centers, Inc. Declares Quarterly Dividend on Common Stock, Payable on July 29, 2022

Chairman & CEO recently bought US$60k worth of stock

First quarter 2022 earnings released: EPS: US$0.44 (vs US$0.32 in 1Q 2021)

Insufficient new directors

Upcoming dividend of US$0.57 per share

Insider recently sold US$115k worth of stock

Now 20% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 21% undervalued after recent price drop

Director exercised options and sold US$110k worth of stock

Upcoming dividend of US$0.57 per share

Senior VP exercised options and sold US$80k worth of stock

Insider exercised options to buy US$134k worth of stock.

Price target increased to US$54.33

Insider recently sold US$131k worth of stock

Price target increased to US$52.00

Third quarter 2021 earnings released: EPS US$0.44 (vs US$0.28 in 3Q 2020)